2021 Brain+ Annual Report

From the CEO:  I am pleased with the Brain+ 2021 annual results we have presented today. With our commitment to develop medical software to detect and treat the cognitive symptoms of dementia, 2021 brought real progress. A few highlights: – Secured first strategic partnership with large pharma company in the main target market, Germany. – […]